Young TIL: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Young TIL

• A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
  NCT02621021 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 1 location
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
  NCT01174121 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 1 location
• T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
  NCT02133196 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Young TIL?

3 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.